The Healthy People, Healthy Region: Driving Corporate Action to Eliminate Malaria in Asia-Pacific private sector meeting was held on May 10, 2016 in Bangkok, Thailand as part of the Joint Malaria Week. Co-organized by the Asian Pacific Leaders Malaria Alliance (APLMA) and the Myanmar Health and Development Consortium (MHDC), with support from Sanofi and Sumitomo Chemical, the meeting brought together … Read More
RBM Partnership Approves Reformed Structure
The Roll Back Malaria Partnership Board approved a new Governance Framework at its 29th Board Meeting in Geneva which will refine and refocus the current Partnership to better advocate for and attract increased attention to the global malaria fight for the next fifteen years. Part of this Board approval will see the creation of a high-level Malaria Council, a Partnership … Read More
Roll Back Malaria Partnership Annual Retreat
The Roll Back Malaria Partnership’s (RBM) Private Sector Members Council met for its Annual Retreat in New York from October 22-23 2015. Hosted by GBCHealth, the meeting provided an opportunity for the Council to discuss the ongoing transition at the RBM Partnership and the proposed Governance Framework of the revitalized Partnership. At the retreat, the PSMC heard further details from … Read More
Meet the Members Council: Jean-Marc Bouchez and Nicole Malick
Jean-Marc Bouchez Chief Medical Officer, General Manager, Guilin Pharmaceutical Co., Ltd. Nicole Malick Corporate Social Responsibility Manager, NRS International (TANA Netting) Tell us a little about your company’s approach to malaria control and elimination. In the last few years, Guilin Pharma has conducted different innovative campaigns and programs in malaria prevention and control. As the innovator of injectable artesunate … Read More
A Closer Look: Malaria R&D Challenges And How To Address Them
Sustaining the gains achieved in malaria control and prevention during the MDG era as we transition to the SDGs will require an ongoing commitment to research and development (R&D) of new tools, including drugs, diagnostics and health products. With up to two-thirds of malaria-endemic countries facing artemisinin resistance, and pyrethroid insecticide resistance rising throughout Africa with no available alternatives, elimination … Read More
RBM Private Sector Members Council News – August 2015
BASF BASF and University of Göttingen Scientists Find New Specific Insecticide Target Protein BAYER Bayer Publishes a view into the future insecticide landscape for malaria vector control EXXONMOBIL ExxonMobil Announces $10 Million in New Grants To Raise Public Awareness of Malaria GUILIN PHARMACEUTICALS Guilin Pharma Launches Anti-Malaria Film In Africa GLAXOSMITHKLINE Positive results from Phase II trial of Malaria vaccine … Read More
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
24 July 2015 | Via GSK WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as … Read More
#PPP4Malaria: Partners Take Action to Defeat Malaria
On the occasion of World Malaria Day, the Global Fund, the U.S. President’s Malaria Initiative (PMI) and the U.S. Centers for Disease Control and Prevention (CDC) joined malaria endemic countries and partners under Roll Back Malaria Partnership’s theme of “Invest in the Future and Defeat Malaria”. As the last World Malaria Day under the MDGs, this year marks a critical … Read More
RBM Partnership Evolves to Align with Sustainable Development Approach
Reposted from the Roll Back Malaria Partnership | 15 May 2015, Geneva The 28th RBM Board meeting, held on the eve of the World Health Assembly, celebrated the remarkable gains made in the fight against one of the world’s oldest and deadliest diseases since the establishment of the Millennium Development Goals (MDG). Most notably, the Board noted that: Annual malaria deaths … Read More
Business Leaders and Health Experts Gather in Yangon for First Regional Meeting on Corporate Sector Engagement in Malaria Control in the Asia-Pacific
(29 September, Yangon, Myanmar) More than 100 leaders from the health, development and corporate sectors have gathered in Yangon to participate in the seminal regional forum on Opportunities for Corporate Sector Engagement in Malaria Control in the Asia-Pacific. In advance of the 2015 enactment of the ASEAN Free Trade Agreement and broader ASEAN economic integration, this one-day meeting seeks to … Read More
- Page 1 of 2
- 1
- 2